VOLITIONRX LTD
VNRX · In Vitro and in Vivo Diagnostic Substances
Latest available SEC filing: 4 ·
Latest disclosures
-
Batchelor Ann-Louise: Form 4
Insider disclosure · Filed · Report period 21 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000093314 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- VNRX on NYSE
- SEC industry group
- In Vitro and in Vivo Diagnostic Substances (Office of Life Sciences)
- Business address
- 1489 West Warm Springs Road, Suite 110, Henderson, NV, 89014
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- STANDARD CAPITAL CORP (to 29 Sep 2011)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields